1. Home
  2. IRBT vs DSGN Comparison

IRBT vs DSGN Comparison

Compare IRBT & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRBT
  • DSGN
  • Stock Information
  • Founded
  • IRBT 1990
  • DSGN 2017
  • Country
  • IRBT United States
  • DSGN United States
  • Employees
  • IRBT N/A
  • DSGN N/A
  • Industry
  • IRBT Consumer Electronics/Appliances
  • DSGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRBT Consumer Discretionary
  • DSGN Health Care
  • Exchange
  • IRBT Nasdaq
  • DSGN Nasdaq
  • Market Cap
  • IRBT 257.0M
  • DSGN 264.4M
  • IPO Year
  • IRBT N/A
  • DSGN 2021
  • Fundamental
  • Price
  • IRBT $6.70
  • DSGN $5.66
  • Analyst Decision
  • IRBT Hold
  • DSGN Hold
  • Analyst Count
  • IRBT 2
  • DSGN 3
  • Target Price
  • IRBT $13.00
  • DSGN $7.00
  • AVG Volume (30 Days)
  • IRBT 1.1M
  • DSGN 128.3K
  • Earning Date
  • IRBT 11-06-2024
  • DSGN 11-19-2024
  • Dividend Yield
  • IRBT N/A
  • DSGN N/A
  • EPS Growth
  • IRBT N/A
  • DSGN N/A
  • EPS
  • IRBT N/A
  • DSGN N/A
  • Revenue
  • IRBT $817,355,000.00
  • DSGN N/A
  • Revenue This Year
  • IRBT N/A
  • DSGN N/A
  • Revenue Next Year
  • IRBT $4.94
  • DSGN N/A
  • P/E Ratio
  • IRBT N/A
  • DSGN N/A
  • Revenue Growth
  • IRBT N/A
  • DSGN N/A
  • 52 Week Low
  • IRBT $5.83
  • DSGN $1.96
  • 52 Week High
  • IRBT $42.14
  • DSGN $6.91
  • Technical
  • Relative Strength Index (RSI)
  • IRBT 39.99
  • DSGN 56.91
  • Support Level
  • IRBT $6.55
  • DSGN $5.22
  • Resistance Level
  • IRBT $10.60
  • DSGN $6.20
  • Average True Range (ATR)
  • IRBT 0.74
  • DSGN 0.32
  • MACD
  • IRBT -0.15
  • DSGN 0.03
  • Stochastic Oscillator
  • IRBT 9.01
  • DSGN 62.61

About IRBT iRobot Corporation

iRobot Corp is a united state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online store. The company derives its revenue from the product sales. It sells the products across the United States and around the world.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

Share on Social Networks: